SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-041847
Filing Date
2024-05-13
Accepted
2024-05-10 18:00:51
Documents
13
Period of Report
2024-05-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0205772-8k_oramed.htm   iXBRL 8-K 24877
  Complete submission text file 0001213900-24-041847.txt   197174

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ormp-20240510.xsd EX-101.SCH 3009
3 XBRL LABEL FILE ormp-20240510_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ormp-20240510_pre.xml EX-101.PRE 22355
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0205772-8k_oramed_htm.xml XML 3688
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35813 | Film No.: 24936323
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)